- Home
- QIPT vs ELTX Comparison
QIPT vs ELTX Comparison
Compare QIPT & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QIPT
- ELTX
- Stock Information
- Founded
- QIPT 1993
- ELTX 2011
- Country
- QIPT United States
- ELTX United States
- Employees
- QIPT N/A
- ELTX N/A
- Industry
- QIPT
- ELTX Biotechnology: Pharmaceutical Preparations
- Sector
- QIPT
- ELTX Health Care
- Exchange
- QIPT Nasdaq
- ELTX Nasdaq
- Market Cap
- QIPT 112.0M
- ELTX 121.7M
- IPO Year
- QIPT N/A
- ELTX N/A
- Fundamental
- Price
- QIPT $2.25
- ELTX $5.17
- Analyst Decision
- QIPT Strong Buy
- ELTX Strong Buy
- Analyst Count
- QIPT 2
- ELTX 2
- Target Price
- QIPT $6.50
- ELTX $9.50
- AVG Volume (30 Days)
- QIPT 125.2K
- ELTX 43.5K
- Earning Date
- QIPT 05-14-2025
- ELTX 05-14-2025
- Dividend Yield
- QIPT N/A
- ELTX N/A
- EPS Growth
- QIPT N/A
- ELTX N/A
- EPS
- QIPT N/A
- ELTX N/A
- Revenue
- QIPT $244,723,000.00
- ELTX N/A
- Revenue This Year
- QIPT $3.35
- ELTX N/A
- Revenue Next Year
- QIPT $5.39
- ELTX N/A
- P/E Ratio
- QIPT N/A
- ELTX N/A
- Revenue Growth
- QIPT 3.82
- ELTX N/A
- 52 Week Low
- QIPT $2.22
- ELTX $3.34
- 52 Week High
- QIPT $4.23
- ELTX $11.45
- Technical
- Relative Strength Index (RSI)
- QIPT 36.51
- ELTX 26.64
- Support Level
- QIPT $2.22
- ELTX $7.54
- Resistance Level
- QIPT $2.42
- ELTX $8.13
- Average True Range (ATR)
- QIPT 0.10
- ELTX 0.58
- MACD
- QIPT 0.01
- ELTX -0.35
- Stochastic Oscillator
- QIPT 15.00
- ELTX 10.22
About QIPT Quipt Home Medical Corp.
Quipt Home Medical Corp provides in-home monitoring equipment, supplies, and services to patients. The Company operates in one business segment, which is the sale and rental of medical equipment and related devices. The company's services consist of Daily and Ambulatory Aides, Power Mobility, INR Self-Testing, Respiratory Equipment Rental, Home ventilation, Oxygen Therapy, and Sleep Apnea and PAP Treatment.
About ELTX Elicio Therapeutics Inc.
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.